David Moore to Reverse Transcriptase Inhibitors
This is a "connection" page, showing publications David Moore has written about Reverse Transcriptase Inhibitors.
Connection Strength
0,092
-
Liver enzymes improve over twenty-four months of first-line non-nucleoside reverse transcriptase inhibitor-based therapy in rural Uganda. AIDS Patient Care STDS. 2008 Oct; 22(10):787-95.
Score: 0,075
-
Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS. 2007 Mar 30; 21(6):685-92.
Score: 0,017